Trial Outcomes & Findings for Measurement of Bispectral Index and Awareness in Patients Undergoing Electrophysiology Studies With Isoproterenol (NCT NCT01377636)

NCT ID: NCT01377636

Last Updated: 2015-02-23

Results Overview

Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. BIS levels were measured continuously before and after isoproterenol administration. Number of participants with increase in BIS reading during anesthetic steady state are reported below. The BIS scale ranges from 0 to 100. The individual's baseline BIS was measured continuously and was maintained in an anesthetic steady state with minimum variance prior to isoproterenol. A deviation from the mean in excess of 3 points (2 STD) was defined categorically as a positive response and was counted dichotomously.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

20 participants

Primary outcome timeframe

During time of Electrophysiology (EP) studies.

Results posted on

2015-02-23

Participant Flow

During the preoperative evaluation for anesthesia, the patients scheduled for catheter ablation for atrial fibrillation were approached by the research associate for informed consent and enrollment into the study. The research consent was separate from the clinical anesthesia and procedural consents.

Participant milestones

Participant milestones
Measure
Pre and Post Isoproterenol Infusion
Bispectral EEG (BIS) monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
Overall Study
STARTED
20
Overall Study
COMPLETED
20
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Measurement of Bispectral Index and Awareness in Patients Undergoing Electrophysiology Studies With Isoproterenol

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
Subjects undergoing catheter ablation for atrial fibrillation had measurements pre and post isoproterenol infusion
Age, Categorical
<=18 years
0 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
n=99 Participants
Age, Categorical
>=65 years
9 Participants
n=99 Participants
Age, Continuous
62 years
STANDARD_DEVIATION 8.2 • n=99 Participants
Sex: Female, Male
Female
5 Participants
n=99 Participants
Sex: Female, Male
Male
15 Participants
n=99 Participants
Region of Enrollment
United States
20 participants
n=99 Participants

PRIMARY outcome

Timeframe: During time of Electrophysiology (EP) studies.

Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. BIS levels were measured continuously before and after isoproterenol administration. Number of participants with increase in BIS reading during anesthetic steady state are reported below. The BIS scale ranges from 0 to 100. The individual's baseline BIS was measured continuously and was maintained in an anesthetic steady state with minimum variance prior to isoproterenol. A deviation from the mean in excess of 3 points (2 STD) was defined categorically as a positive response and was counted dichotomously.

Outcome measures

Outcome measures
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
Number of Participants With an Increase in BIS Readings During Steady State
19 participants

PRIMARY outcome

Timeframe: Within 20 minutes of starting isoproterenol infusion

The BIS scale ranges from 0 to 100. The individual's baseline BIS was measured continuously and was maintained in an anesthetic steady state with minimum variance prior to isoproterenol. A deviation from the mean in excess of 3 points (2 STD) was defined categorically as a positive response and was counted dichotomously.The difference between Pre-BIS and Post-BIS was calculated.

Outcome measures

Outcome measures
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
BIS Change
24.6 units on a scale
Interval 19.3 to 29.9

SECONDARY outcome

Timeframe: Within 20 minutes of starting isoproterenol infusion

Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. Patients under steady state total venous anesthesia (TIVA) with propofol and remifentanil infusions with BIS around 50 normally do not move even in the absence of neuromuscular blockade. Spontaneous movement appearing like restlessness during sleep is unusual. Several patients under anesthesia after isoproterenol appear to wake up and move spontaneously.

Outcome measures

Outcome measures
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
Number of Participants With Spontaneous Musculoskeletal Movement
12 participants

SECONDARY outcome

Timeframe: Within 20 minutes of starting isoproterenol infusion

Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. Ability to follow verbal commands before and after isoproterenol infusion was assessed by asking subjects to "squeeze my hands".

Outcome measures

Outcome measures
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
Number of Participants Who Follow Verbal Command to Squeeze Hands
10 participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Within 20 minutes of starting isoproterenol infusion

Heart rate measured by standard EKG monitor during anesthesia. Pre- and Post Heart rates where noted. An increase of 8 percent or more was defined as a significant change in heart rate.

Outcome measures

Outcome measures
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
Number of Participants With Significant Change in Heart Rate
18 participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Within 20 minutes of starting isoproterenol infusion

Non-Invasive Blood Pressure (NIBP) is measured routinely as part of an anesthetic. Pre- and Post Blood Pressures where noted. An increase or decrease of 10 percent or more was defined as a significant change in systolic blood pressure.

Outcome measures

Outcome measures
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
Number of Participants With Change in Blood Pressure
13 participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Within one hour of completing anesthesia

Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation. Specific pre-determined test words were spoken to the subject during administration of isoproterenol. After anesthesia, patients were tested for possible recall of those specific words. If no words were recalled, the result was categorically defined as amnesia.

Outcome measures

Outcome measures
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
Number of Participants With Amnesia or No Recall During Steady State
20 participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Within 20 minutes of start of isoproterenol

Increasing doses of isoproterenol (5,10,15,20 mcg/minute) were administered to patients undergoing catheter ablation for atrial fibrillation after return to sinus rhythm. If a non-sinus arrhythmia resulted from the infusion, the arrhythmia was defined categorically as a positive response and was counted dichotomously.

Outcome measures

Outcome measures
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
Number of Participants With New Arrhythmia During Steady State.
4 participants

OTHER_PRE_SPECIFIED outcome

Timeframe: Within 20 minutes of starting isoproterenol infusion

The (ST) segment on the EKG was monitored for changes suggestive of demand ischemia. An observable EKG change compared to baseline was defined categorically as a positive response and was counted dichotomously.

Outcome measures

Outcome measures
Measure
Pre and Post Isoproterenol Infusion
n=20 Participants
BIS monitoring and neurological examinations were repeated throughout an isoproterenol infusion protocol (20 minutes maximum) to measure the changes in arousal and ability to follow commands under anesthesia
Number of Participants Who Developed Ischemia or ST Segment Changes
2 participants

Adverse Events

Pre and Post Isoproterenol Infusion

Serious events: 0 serious events
Other events: 19 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Pre and Post Isoproterenol Infusion
n=20 participants at risk
In this study, serious adverse events were considered clinically significant adverse events. The well known isoproterenol effects on heart rate, rhythm, ST segments, and blood pressure were noted.
Cardiac disorders
Death
0.00%
0/20 • 24 hours
Nervous system disorders
Stroke
0.00%
0/20 • 24 hours
Nervous system disorders
Seizure
0.00%
0/20 • 24 hours
Cardiac disorders
Cardiac arrest
0.00%
0/20 • 24 hours

Other adverse events

Other adverse events
Measure
Pre and Post Isoproterenol Infusion
n=20 participants at risk
In this study, serious adverse events were considered clinically significant adverse events. The well known isoproterenol effects on heart rate, rhythm, ST segments, and blood pressure were noted.
Cardiac disorders
Tachycardia
95.0%
19/20 • Number of events 19 • 24 hours
Cardiac disorders
Atrial Fibrillation/Junctional Rhythm
20.0%
4/20 • Number of events 4 • 24 hours
Cardiac disorders
ST Changes (transient)
10.0%
2/20 • Number of events 2 • 24 hours
Cardiac disorders
Hypotension
30.0%
6/20 • Number of events 6 • 24 hours
Cardiac disorders
Hypertension
30.0%
6/20 • Number of events 6 • 24 hours
Cardiac disorders
Bradycardia
0.00%
0/20 • 24 hours
Cardiac disorders
Ventricular arrhythmia
0.00%
0/20 • 24 hours
Respiratory, thoracic and mediastinal disorders
Bronchospasm
0.00%
0/20 • 24 hours
Respiratory, thoracic and mediastinal disorders
Pneumonia
0.00%
0/20 • 24 hours
Blood and lymphatic system disorders
Bleeding
0.00%
0/20 • 24 hours
Respiratory, thoracic and mediastinal disorders
Pulmonary embolism
0.00%
0/20 • 24 hours

Additional Information

Patrick Linton, MD, Director of Adult Off-Site Anesthesia Services

New York University Langone Medical Center, Anesthesiology

Phone: 212-263-5072

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place